metaLead Therapeutics
Z├╝rich · Founded 2023
About metaLead Therapeutics
metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Company Facts
- Founded: 2023
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.9M
- Funding stage: Seed
- Last round: Seed (May 2025)
- Website: https://metalead.ch
Industries & Categories
Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/metalead-therapeutics-111473 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.